Hepatitis C virus infkction in the United States

Hepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States, and most infected persons are younger than 50 years old. The relative importance of the two most common exposures associated with transmission of HCY blood transfusion and intravenous drug use (IVDU), has changed over time. Blood transfusion, which accounted for a substantial proportion of HCV infections acquired >lO years ago, rarely accounts for recently acquired infections. In contrast, IVDU has consistently accounted for a substantial proportion of HCV infectious and currently accounts for 60% of HCV transmission while sexual exposures account for up to 20%. Other known exposures (occupational, hemodialysis, household, perinatal) together account for about 10% of infections. In the remaining lo%, no recognized source of infection can be identified, although most persons in this category are associated

[1]  H. Margolis,et al.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease , 1998 .

[2]  M. Alter,et al.  Epidemiology of Hepatitis C , 2018, Clinical liver disease.

[3]  J W Shih,et al.  Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. , 1996, The New England journal of medicine.

[4]  T. Quinn,et al.  Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. , 1996, The American journal of medicine.

[5]  A. Panlilio,et al.  Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. , 1995, Journal of the American College of Surgeons.

[6]  Jennifer Y. Liu,et al.  Hepatitis C virus infection in sexually active homosexual men. , 1994, The Journal of infection.

[7]  M. Alter,et al.  Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. , 1994, The Journal of infectious diseases.

[8]  M. Alter,et al.  Risk factors for hepatitis C virus infection among health care personnel in a community hospital. , 1993, American journal of infection control.

[9]  T. Quinn,et al.  Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. , 1993, Archives of internal medicine.

[10]  A. Reingold,et al.  Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. , 1993, JAMA.

[11]  H. Sheppard,et al.  Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. , 1993, The Journal of infectious diseases.

[12]  M A Gerber,et al.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. , 1992, The New England journal of medicine.

[13]  S. Gordon,et al.  Lack of evidence for the heterosexual transmission of hepatitis C. , 1992, The American journal of gastroenterology.

[14]  B. Cooper,et al.  Seroprevalence of Antibodies to Hepatitis C Virus in High-Risk Hospital Personnel , 1992, Infection Control & Hospital Epidemiology.

[15]  J. Goedert,et al.  Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). , 1991, Annals of internal medicine.

[16]  J. Gumucio,et al.  Potential importance of the sexual transmission of non‐A, non‐B hepatitis , 1991, Hepatology.

[17]  H. Margolis,et al.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. , 1990, JAMA.

[18]  J. Hoofnagle,et al.  Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. , 1990, Annals of internal medicine.

[19]  M. Alter,et al.  Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. , 1982, The Journal of infectious diseases.

[20]  D. Bradley,et al.  Non-A, non-B hepatitis among participants in a plasmapheresis stimulation program. , 1979, The Journal of infectious diseases.